Tom de Swaan
Major Career Roles:
- Chair of the Supervisory Board of ABN AMRO Bank N.V
- Chair of the National Opera & Ballet Fund
- Chair of the Foundation Funds Netherland Cancer Institute
- Member of the Advisory Board of the Akbank Turk Anonim Sirketi AS
- Member of the Board of Directors of the International Centre of Missing & Exploited Children
Other Career Highlights:
- Member of the Governing Board of De Nederlandsche Bank
- Member of the Executive Board, CFO, CRO of the ABN AMRO Bank NV
- Chair and CEO a.i. of the Zurich Insurance Group AG
- Vice Chair of the Supervisory Board of Royal DSM NV
- Chair of the Supervisory Board of Van Lanschot Bankiers
- Member of the Board of Directors of GSK plc
- Advisory Board Member of the China Banking Regulatory Commission
- Vice Chair of the Supervisory Board of the Royal Ahold NV
- Chair Basel Committee, Banking Supervision
- Chair of the Amsterdam Financial Centre and the Banking Supervisory Sub-Committee of the European Monetary Institute
Tom de Swaan has over 20 years of international senior leadership experience from working as a Chair for AEX, EURONEXT 100, SMI, STOXX EUROPE 50 and other private and public companies. This has given him a multi-industry knowledge in financial services, insurance, chemicals, government, and pharmaceuticals
Tom de Swaan is Chair of the Supervisory Board of ABN AMRO Bank N.V. He is also an Advisory Board Member of Akbank Turk Anonim Sirketi AS. He was previously Chair of Zurich Insurance Group AG, Vice Chair of the Supervisory Board of Royal DSM NV, a Netherlands-based global life-sciences and material-sciences group, Vice Chair of the Supervisory Board of Royal Ahold NV, a multi-country supermarket chain, Chair of the Amsterdam Financial Centre and the Banking Supervisory Sub-Committee of the European Monetary Institute.
He was a member of the Governing Board of De Nederlandsche Bank, a member of the Executive Board and CFO of ABN AMRO, and CEO a.i. of the Board of the Zurich Insurance Group.
Tom has developed a broad portfolio of corporate and not-for-profit activities, and has served on several Boards, including as a member of the Supervisory Board of Van Lanschot Kempen NV, the holding company of an independent Dutch bank, where he served as Chair until the end of 2015. He was also a member of the Advisory Board of the China Banking Regulatory Commission in Beijing from 2009 to 2017.
Tom is also Chairman of the Foundation Funds of the Netherlands Cancer Institute. On the not for profit side he is at present, among others, Chair of the Board of the National Opera & Ballet Fund and member of the Supervisory Board of the Holland Festival.
